| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 7.943 | 9.244 | 32.791 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 0 | 20.448 | 12.509 | 35.994 | 3.132 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | 1.239 | 31.070 | 27.964 | 23.907 | 3.875 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | - | -1.239 | -10.623 | -15.455 | 12.087 | -744 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | -1.239 | -10.702 | -15.548 | 11.792 | -744 | 0 | 0 | 0 |
| Employees | - | - | 0 | 3 | 2 | 2 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Plamadire Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 604 | 32.825 | 28.074 | 23.505 | 19.303 | 19.363 | 19.305 | 19.197 |
| Current Assets | - | - | 20.628 | 7.569 | 104 | 99 | 106 | 107 | 106 | 106 |
| Inventories | - | - | 0 | 361 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 5.281 | 0 | 69 | 67 | 66 | 66 | 66 | 66 |
| Cash | - | - | 15.346 | 7.208 | 35 | 32 | 40 | 41 | 40 | 40 |
| Shareholders Funds | - | - | -1.195 | -11.875 | -27.193 | -14.886 | -15.300 | -15.347 | -15.301 | -15.215 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 22.426 | 27.129 | 33.982 | 20.709 | 20.454 | 20.518 | 20.455 | 20.341 |
| Income in Advance | - | - | 0 | 25.140 | 21.389 | 17.781 | 14.255 | 14.299 | 14.256 | 14.176 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1071 - 1071" | |||||||||
| CAEN Financial Year |
1071
|
|||||||||
Comments - Plamadire Bio Srl